🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Ohio › Cincinnati

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Cincinnati, OH keessatti

Qorannoo 6 Kansaar Onnee Triple-Negative f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Namoota walitti qabaa jiraSadarkaa 3
  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0044), Edgewood · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Namoota walitti qabaa jiraSadarkaa 3
  • Good Samaritan Hospital, Cincinnati
  • Oncology Hematology Care, Inc., Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05633654

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Cincinnati Medical Center, Cincinnati
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07211178

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Namoota walitti qabaa jiraSadarkaa 2
  • The Christ Hospital Cancer Center, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT04468061

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Christ Hospital, Cincinnati
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Sad-2025 · NCT05902988

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Cincinnati keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.